Quick Answer
Journey Medical Corp reported Long Term Debt of $25.28 million for the year ending 2025.
- Journey Medical Corp showed an increase of +1.6% in Long Term Debt from 2024 to 2025.
- This data is from Journey Medical Corp's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $14.78 million | Q2 2022: $14.79 million | Q3 2022: $19.81 million | Q1 2023: $9.93 million | Q1 2024: $14.68 million | Q2 2024: $19.75 million | Q3 2024: $19.79 million | Q1 2025: $23.11 million | Q2 2025: $21.36 million | Q3 2025: $19.53 million.
- Over the full 4 years of available data (2022 to 2025), Journey Medical Corp's Long Term Debt has grown by 27.5%.
- Historical annual values: Fiscal year 2025: $25.28 million | Fiscal year 2024: $24.88 million | Fiscal year 2023: $14.62 million | Fiscal year 2022: $19.83 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: